We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$40.3B
AUM Growth
-$672M
Cap. Flow
-$694M
Cap. Flow %
-1.72%
Top 10 Hldgs %
14.49%
Holding
2,585
New
23
Increased
499
Reduced
843
Closed
72

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$297M
2
TPR icon
Tapestry
TPR
+$225M
3
SLB icon
SLB Ltd
SLB
+$167M
4
QCOM icon
Qualcomm
QCOM
+$165M
5
AMAT icon
Applied Materials
AMAT
+$163M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$197M
2
NKE icon
Nike
NKE
+$187M
3
JAH
JARDEN CORPORATION
JAH
+$185M
4
INTC icon
Intel
INTC
+$177M
5
CTSH icon
Cognizant
CTSH
+$171M

Sector Composition

Rank Sector Weight
1 Technology 15.25%
2 Healthcare 14.2%
3 Consumer Discretionary 12.55%
4 Financials 12.15%
5 Industrials 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GCAP
2401
DELISTED
Gain Capital Holdings, Inc.
GCAP
$98K ﹤0.01%
14,907
– –
KEYW
2402
DELISTED
The KEYW Holding Corporation
KEYW
$98K ﹤0.01%
14,742
– –
BCRX icon
2403
BioCryst Pharmaceuticals
BCRX
$2.69B
$97K ﹤0.01%
34,148
– –
HOV icon
2404
Hovnanian Enterprises
HOV
$799M
$97K ﹤0.01%
2,483
– –
CMRX
2405
DELISTED
Chimerix, Inc.
CMRX
$97K ﹤0.01%
18,987
– –
IIP
2406
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$97K ﹤0.01%
35,667
– –
OPCH icon
2407
Option Care Health
OPCH
$3.63B
$95K ﹤0.01%
11,154
– –
VIVS
2408
VivoSim Labs
VIVS
$1.24M
$95K ﹤0.01%
183
– –
ARAV
2409
DELISTED
Aravive, Inc. Common Stock
ARAV
$95K ﹤0.01%
1,978
– –
RELY
2410
DELISTED
Real Industry, Inc.
RELY
$95K ﹤0.01%
10,906
– –
KPTI icon
2411
Karyopharm Therapeutics
KPTI
$47.6M
$94K ﹤0.01%
704
– –
PTCT icon
2412
PTC Therapeutics
PTCT
$6.17B
$94K ﹤0.01%
14,593
– –
SZYM
2413
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$94K ﹤0.01%
46,323
– –
CYTR
2414
DELISTED
CytRx Corp
CYTR
$94K ﹤0.01%
5,877
– –
RGLS
2415
DELISTED
Regulus Therapeutics
RGLS
$93K ﹤0.01%
111
– –
MCHX icon
2416
Marchex
MCHX
$76.2M
$92K ﹤0.01%
20,566
– –
AREX
2417
DELISTED
Approach Resources Inc.
AREX
$92K ﹤0.01%
79,728
– –
DRRX
2418
DELISTED
DURECT Corp
DRRX
$91K ﹤0.01%
6,743
– –
ACTG icon
2419
Acacia Research
ACTG
$458M
$90K ﹤0.01%
23,813
– –
CRIS icon
2420
Curis
CRIS
$4.64M
$90K ﹤0.01%
28
– –
VALE.P
2421
DELISTED
Vale S A
VALE.P
$90K ﹤0.01%
28,871
-20,600
-42% -$47.4K
MOBL
2422
DELISTED
MobileIron, Inc.
MOBL
$90K ﹤0.01%
19,907
– –
RDNT icon
2423
RadNet
RDNT
$5.96B
$88K ﹤0.01%
18,180
– –
PETX
2424
DELISTED
Aratana Therapeutics, Inc.
PETX
$88K ﹤0.01%
15,920
– –
OPWR
2425
DELISTED
OPOWER INC COM STK (DE)
OPWR
$88K ﹤0.01%
12,884
– –
95 96
97
98 99

Similar funds

Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

VOYA Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, VOYA Investment Management held 2,585 positions worth $40.3B, down 1.6% from $41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 3.7%. VOYA Investment Management opened 23 new positions and exited 72, leaving the 2,585-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • VOYA Investment Management's largest Q1 2016 buy was AstraZeneca: 495,025 shares worth $27.9M.
  • VOYA Investment Management added most to AbbVie in Q1 2016, an estimated $297M increase.
  • VOYA Investment Management's biggest Q1 2016 reduction was Pfizer, cutting an estimated $197M.
  • VOYA Investment Management fully exited Blackstone in Q1 2016, selling an estimated $61.8M.
  • VOYA Investment Management's ten largest holdings make up 14% of its $40.3B portfolio in Q1 2016.
  • VOYA Investment Management opened 23 new positions and closed 72 in Q1 2016.
  • VOYA Investment Management's portfolio value fell 1.6% quarter-over-quarter to $40.3B.

Based on VOYA Investment Management's 13F filing for Q1 2016, filed 16 May 2016.